Diprogenta

Diprogenta

betamethasone + gentamicin

Manufacturer:

Merck Sharp & Dohme

Marketer:

Transfarma Medica Indah
Concise Prescribing Info
Contents
Betamethasone dipropionate 0.05%, gentamicin sulfate 0.1%
Indications/Uses
Reduce inflammatory manifestations of corticosteroid-responsive dermatoses complicated by secondary infection.
Dosage/Direction for Use
Special Precautions
Discontinue if irritation or sensitization develops. Avoid long-term use & treatment of extensive BSA. Not for ophth use. Pregnancy & lactation. Childn.
Adverse Reactions
Burning, itching, irritation, dryness, folliculitis, hypertrichosis, perioral dermatitis, allergic contact dermatitis, acneiform eruption, hypopigmentation, skin maceration & atrophy, secondary infection, striae & miliaria; transient irritation (erythema & pruritus).
ATC Classification
D07CC01 - betamethasone and antibiotics ; Belongs to the class of potent (group III) corticosteroids, in combination with antibiotics. Used in the treatment of dermatological diseases.
Presentation/Packing
Form
Diprogenta cream
Packing/Price
10 g x 1's;5 g x 1's
Form
Diprogenta oint
Packing/Price
10 g x 1's;5 g x 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in